Selected outcomes in 2016
During working and utilization of our large research infrastructure BBMRI.cz were created plenty of unique outcomes. Here we mention some of them:
- Drábek, J., Smolíková, M., Kalendar, R., Pinto, F.A., Pavloušek, P., Klepárník, K., Frébort, I. Design and validation of an STR hexaplex assay for DNA profiling of grapevine cultivars. Electrophoresis 2016;37(23-24):3059-3067. doi: 10.1002/elps.201600068. (IF2015: 2,482)
- Dvořáková, M., Jeřábková, J., Procházková, I., Lenčo, J., Nenutil, R., Bouchal, P. Transgelin is upregulated in stromal cell sof lymf node positive breast cancer. J Proteomics 2016;132:103-111. doi: 10.1016/j.jprot.2015.11.025. (IF2015: 3,867)
- Hezova, R., Kovarikova, A., Srovnal, J., Zemanova, M., Harustiak, T., Ehrmann, J., Hajduch, M., Sachlova, M., Svoboda, M., Slaby, O. MiR-205 functions as a tumor suppressor in adenocarcinoma and an oncogene in squamous cell carcinoma of esophagus. Tumour Biol 2016;37(6):8007-8018. doi: 10.1007/s13277-015-4656-8. (IF2015: 3,611)
- Koudelakova, V., Trojanec, R., Vrbkova, J., Donevska, S., Bouchalova, K., Kolar, Z., Varanasi, L., Hajduch, M. Frequency of chromosome 17 polysomy in relation to CEP17 copy number in a large breast cancer cohort. Genes Chromosomes Cancer 2016;55(5):409-417. doi: 10.1002/gcc.22337. (IF2015: 3,960)
- Lakka Klement, G., Arkun, K., Valik, D., Roffidal, T., Hashemi, A., Klement, C., Carmassi, P., Rietman, E., Slaby, O., Mazanek, P., Mudry, P., Kovacs, G., Kiss, C., Norga, K., Konstantinov, D., André, N., Slavc, I., Van Den Berg, H., Kolenova, A., Kren, L., Tuma, J., Skotakova, J., Sterba, J. Future paradigms for precision oncology. Oncotarget 2016;7(29):46813-46831. doi: 10.18632/oncotarget.9488. (IF2015: 5,008; Q1)
- Machackova, T., Mlcochova, H., Stanik, M., Dolezel, J., Fedorko, M., Pacik, D., Poprach, A., Svoboda, M., Slaby, O. MiR-429 is linked to metastasis and poor prognosis in renal cell carcinoma by affecting epithelial-mesenchymal transition. Tumour Biol 2016;37(11):14653-14658. doi: 10.1007/s13277-016-5310-9. (IF2015: 2,926)
- Mlcochova, H., Machackova, T., Rabien, A., Radova, L., Fabian, P., Iliev, R., Slaba, K., Poprach, A., Kilic, E., Stanik, M., Redova-Lojova, M., Svoboda, M., Dolezel, J., Vyzula, R., Jung, K., Slaby, O. Epithelial-mesenchymal transition-associated microRNA/mRNA signature is linked to metastasis and prognosis in clear-cell renal cell carcinoma. Sci Rep 2016;6:31852. doi: 10.1038/srep31852. (IF2015: 5,228; Q1)
- Ryška, A. Molecular pathology in real time. Cancer Metastasis Rev 2016;35(1):129-140. doi: 1007/s10555-016-9607-3. (IF2015: 5,316)
- Thorenoor, N., Faltejskova-Vychytilova, P., Hombach, S., Mlcochova, J., Kretz, M., Svoboda, M., Slaby, O. Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer. Oncotarget 2016;7(1):622-637. doi: 10.18632/oncotarget.5807. (IF2015: 5,008)
- Vychytilova-Faltejskova, P., Radova, L., Sachlova, M., Kosarova, Z., Slaba, K., Fabian, VyzulaP., Grolich, T., Prochazka, V., Kala, Z., Svoboda, M., Kiss, I., , R., Slaby, O. Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. Carcinogenesis 2016;37(10):941-950. doi: 10.1093/carcin/bgw078. (IF2015: 4,874)